Dermatology News

According to published results, prophylactic intraoperative incisional wound irrigation with an antiseptic solution was associated with reduced surgical site infections compared with use of either an antibiotic solution or no irrigation.

Ritlecitinib was well tolerated and safe when continually used to treat alopecia areata in patients aged 12 years and older, according to a study.

As cases of botulism-like illnesses continue to rise, the CDC has issued a Health Alert Network Health Advisory to warn clinicians about risks associated with counterfeit or mishandled botulinum toxin injections.

Dupilumab demonstrated sustained effectiveness across patientreported outcome measures in adult and pediatric individuals with atopic dermatitis, according to a study.

Incyte and Escient Pharmaceuticals have entered a definitive agreement under which Incyte will acquire Escient for $750 million, the companies announced in a press release.

In a 3-2 vote, the Federal Trade Commission passed a final rule that bans new noncompete agreements with all workers in for-profit organizations.

Adults and adolescents with moderate to severe atopic dermatitis treated with upadacitinib reported year-long improvements in skin symptoms, mental health and quality of life, according to a study.

The FDA did not approve Abeona Therapeutics’ biologics license application for prademagene zamikeracel for recessive dystrophic epidermolysis bullosa, the company announced in a press release.

Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts.